Provided by Chambers
Fried, Frank, Harris, Shriver & Jacobson LLP has a versatile transactional and regulatory practice boasting strengths in OTC and exchange-traded derivatives. It is frequently sought for its regulatory expertise, which includes handling matters before the SEC and CFTC. Clients range from asset managers to major corporates across a broad range of industries, including emerging sectors.
Provided by Fried, Frank, Harris, Shriver & Jacobson LLP
Fried, Frank, Harris, Shriver & Jacobson LLP advised NiSource on the securities law issues related to its April 2021 registered convertible units offering.
Provided by Chambers
"The Fried, Frank team understands our business goals and prioritizes deliverables across many work-streams."
"The Fried, Frank team is commercially aware, practical and provides precise advice."
"The lawyers are extremely knowledgeable, capable and have excellent coverage."
"The Fried, Frank team understands our business goals and prioritizes deliverables across many work-streams."
"The Fried, Frank team is commercially aware, practical and provides precise advice."
"The lawyers are extremely knowledgeable, capable and have excellent coverage."
Provided by Chambers
Ray Shirazi is well regarded for his transactional and regulatory acumen in matters involving derivatives.
"Ray has thorough knowledge of all things derivatives and has a strong sense of how the market views various issues."
"Ray is a fantastic partner and provides an excellent service level."
David Mitchell is a well-regarded OTC derivatives practitioner and he boasts an impressive regulatory practice.
"David is extremely thoughtful and thinks about things from a legal and business perspective."
"He is truly encyclopedic and incredibly smart. David produces incredible results."
Nihal Patel earns praise for his ability to counsel key market players, including financial institutions and trade associations, among others, on derivatives transactions and market developments.
"Nihal is commercial, practical, knowledgeable and solutions-oriented."
Robert McLaughlin serves as head of the derivatives group and has a comprehensive OTC practice, regularly advising asset managers and companies on a variety of mandates.